Fasting Versus Post-Load Plasma Glucose Concentration and the Risk for Future Type 2 Diabetes: Results From The Botnia Study
- Muhammad A Abdul-Ghani, MD, PhD (abdulghani{at}uthscsa.edu)1,
- Valeriya Lyssenko, M.D., PhD.2,
- Tiinamaija Tuomi, MD, PhD2,
- Ralph A DeFronzo, MD1 and
- Leif Groop, MD2
- 1Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, Texas
- 2Department of Clinical Sciences, Diabetes and Endocrinology, and Lund University Diabetes Center, Lund University, Malmö, Sweden
Abstract
Aim: To assess the efficacy of post-load plasma glucose concentration in predicting future risk of T2DM, compared to prediction models based upon measurement of the fasting plasma glucose (FPG) concentration.
Research Design and Methods: 2442 subjects from the Botnia Study, who were free of T2DM at baseline, received an OGTT at baseline and after 7-8 years of follow. Future risk for T2DM was assessed with area under the ROC for prediction models based upon measurement of the FPG (i) with or without 1-h PG during the OGTT and (ii) with or without the metabolic syndrome.
Results: Prediction models based on measurement of the FPG were weak predictors for the risk of future T2DM. Addition of 1-h PG markedly enhanced the prediction the risk of future T2DM. A cut point of 155 mg/dl for the 1-h PG during OGTT and presence of the metabolic syndrome were used to stratify subjects in each glucose tolerance group into low, intermediate and high risk for future T2DM.
Conclusion: The plasma glucose concentration at 1 hour during the OGTT is a strong predictor of future risk for T2DM and adds to the prediction power of models based upon measurements made during the fasting state. A plasma glucose cut point of 155 mg/dl plus the ATP III criteria for the metabolic syndrome can be used to stratify non-diabetic subjects into low, intermediate and high risk groups.
Footnotes
-
- Received July 8, 2008.
- Accepted October 30, 2008.
- Copyright © 2008 American Diabetes Association














